Patents by Inventor Sebastien M. Ferrandon

Sebastien M. Ferrandon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified chitin binding domain and uses thereof
    Patent number: 7060465
    Abstract: Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: June 13, 2006
    Assignee: New England Biolabs, Inc.
    Inventors: Ming-qun Xu, Sebastien M. Ferrandon, Christopher H. Taron, Paul A. Colussi
  • Modified chitin-binding domain and use thereof
    Patent number: 6987007
    Abstract: Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
    Type: Grant
    Filed: April 20, 2005
    Date of Patent: January 17, 2006
    Assignee: New England Biolabs, Inc.
    Inventors: Ming-Qun Xu, Sebastien M. Ferrandon
  • Modified chitin-binding domain and use thereof
    Patent number: 6984505
    Abstract: Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
    Type: Grant
    Filed: April 20, 2005
    Date of Patent: January 10, 2006
    Assignee: New England Biolabs, Inc.
    Inventors: Ming-Qun Xu, Sebastien M. Ferrandon
  • Modified chitin binding domain and uses thereof
    Patent number: 6897285
    Abstract: Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: May 24, 2005
    Assignee: New England Biolabs, Inc.
    Inventors: Ming-Qun Xu, Sebastien M. Ferrandon, Christopher H. Taron, Paul A. Colussi
  • Modified chitin binding domain and uses thereof
    Publication number: 20030216550
    Abstract: Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
    Type: Application
    Filed: February 26, 2003
    Publication date: November 20, 2003
    Applicant: New England Biolabs, Inc.
    Inventors: Ming-Qun Xu, Sebastien M. Ferrandon, Christopher H. Taron, Paul A. Colussi